| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| TERN | Terns Pharmaceuticals Inc | 13.96% | 5,346,928 | $216,015,891 | -1,548,818 | -22.46% | $40.4 | 13F |
| CDTX | Cidara Therapeutics, Inc. | 13.66% | 956,670 | $211,318,836 | -354,755 | -27.05% | $220.89 | 13F |
| PRAX | Praxis Precision Medicines | 6.27% | 328,895 | $96,938,512 | 130,000 | 65.36% | $294.74 | 13F |
| COGT | Cogent Biosciences Inc | 5.51% | 2,398,993 | $85,212,231 | -390,144 | -13.99% | $35.52 | 13F |
| TRVI | Trevi Therapeutics Inc | 4.12% | 5,094,668 | $63,785,243 | No Change | $12.52 | 13F | |
| AVDL | Avadel Pharmaceuticals PLC | 3.74% | 2,684,109 | $57,842,549 | No Change | $21.55 | 13F | |
| CMPX | Compass Therapeutics Inc | 3.31% | 9,545,466 | $51,259,152 | No Change | $5.37 | 13F | |
| DYN | Dyne Therapeutics Inc | 3.31% | 2,614,960 | $51,148,618 | No Change | $19.56 | 13F | |
| ABVX | Abivax SA - ADR | 3.13% | 359,305 | $48,454,076 | No Change | $134.86 | 13F | |
| DBVT | DBV Technologies SA | 3.05% | 2,461,626 | $47,189,370 | 1,407,120 | 133.44% | $19.17 | 13F |
| SABS | SAB Biotherapeutics Inc | 2.76% | 11,420,000 | $42,710,800 | No Change | $3.74 | 13F | |
| SLNO | Soleno Therapeutics Inc | 2.68% | 894,909 | $41,434,287 | -1,383,294 | -60.72% | $46.3 | 13F |
| DRUG | Bright Minds Biosciences Inc | 2.53% | 501,617 | $39,146,191 | No Change | $78.04 | 13F | |
| SVA | Sinovac Biotech Ltd. | 2.47% | 5,903,000 | $38,192,410 | No Change | $6.47 | 13F | |
| GERN | Geron Corp | 2.32% | 27,225,292 | $35,937,385 | No Change | $1.32 | 13F | |
| ERAS | Erasca Inc | 2.23% | 9,273,428 | $34,497,152 | No Change | $3.72 | 13F | |
| ZBIO | Zenas Biopharma Inc | 2% | 853,495 | $30,990,403 | -329,765 | -27.87% | $36.31 | 13F |
| VRDN | Viridian Therapeutics Inc | 1.98% | 982,576 | $30,577,765 | No Change | $31.12 | 13F | |
| ACRS | Aclaris Therapeutics, Inc. | 1.73% | 8,888,888 | $26,755,553 | No Change | $3.01 | 13F | |
| CAMP | CAMP4 Therapeutics Inc | 1.68% | 4,246,568 | $26,031,462 | 325,000 | 8.29% | $6.13 | 13F |
| TNGX | Tango Therapeutics Inc | 1.23% | 2,154,780 | $19,091,351 | 1,378,081 | 177.43% | $8.86 | 13F |
| ANRO | Alto Neuroscience Inc | 1.19% | 1,035,551 | $18,432,808 | 1,035,551 | New | $17.8 | 13F |
| LBRX | LB Pharmaceuticals Inc | 1.15% | 800,000 | $17,808,000 | No Change | $22.26 | 13F | |
| NERV | Minerva Neurosciences Inc | 1.12% | 4,322,747 | $17,377,443 | 4,322,747 | New | $4.02 | 13F |
| ORIC | Oric Pharmaceuticals Inc | 1.12% | 2,118,384 | $17,328,381 | -1,008,220 | -32.25% | $8.18 | 13F |
| CRVS | Corvus Pharmaceuticals Holdings | 1.11% | 2,234,566 | $17,206,158 | No Change | $7.7 | 13F | |
| OLMA | Olema Pharmaceuticals Inc | 1.09% | 671,843 | $16,796,075 | -834,019 | -55.38% | $25 | 13F |
| DSGN | Design Therapeutics Inc | 0.98% | 1,612,903 | $15,129,030 | 1,612,903 | New | $9.38 | 13F |
| PEPG | Pepgen Inc | 0.98% | 2,325,000 | $15,135,750 | No Change | $6.51 | 13F | |
| DNTH | Dianthus Therapeutics Inc | 0.94% | 353,998 | $14,588,258 | No Change | $41.21 | 13F | |
| MLTX | Moonlake Immunotherapeutics | 0.85% | 1,000,000 | $13,180,000 | 1,000,000 | New | $13.18 | 13F |
| CTMX | Cytomx Therapeutics Inc | 0.79% | 2,884,615 | $12,288,460 | No Change | $4.26 | 13F | |
| UNCY | Unicycive Therapeutics | 0.67% | 1,789,916 | $10,327,815 | No Change | $5.77 | 13F | |
| EPRX | Eupraxia Pharmaceuticals Inc | 0.66% | 1,350,000 | $10,192,500 | No Change | $7.55 | 13F | |
| ABEO | Abeona Therapeutics, Inc. | 0.63% | 1,842,751 | $9,711,298 | No Change | $5.27 | 13F | |
| VSTM | Verastem Inc | 0.55% | 1,106,524 | $8,542,365 | -1,538,461 | -58.17% | $7.72 | 13F |
| SLN | Silence Therapeutics PLC | 0.43% | 1,105,454 | $6,721,160 | No Change | $6.08 | 13F | |
| MNPR | Monopar Therapeutics Inc | 0.38% | 90,500 | $5,909,650 | No Change | $65.3 | 13F | |
| SRZN | Surrozen Inc | 0.38% | 260,000 | $5,876,000 | No Change | $22.6 | 13F | |
| PALI | Palisade Bio Inc | 0.35% | 2,293,578 | $5,389,908 | 2,293,578 | New | $2.35 | 13F |
| SERA | Sera Prognostics Inc | 0.31% | 1,650,440 | $4,868,798 | No Change | $2.95 | 13F | |
| TIL | Instil Bio Inc | 0.21% | 292,743 | $3,220,173 | No Change | $11 | 13F | |
| KTTA | Pasithea Therapeutics Corp | 0.18% | 2,100,000 | $2,709,000 | 2,100,000 | New | $1.29 | 13F |
| TENX | Tenax Therapeutics Inc | 0.16% | 208,333 | $2,539,579 | No Change | $12.19 | 13F | |
| ENGNW | EnGene Holdings Inc | 0.05% | 285,046 | $843,736 | 285,046 | New | $2.96 | 13F |
| BOLT | Bolt Therapeutics Inc | 0.03% | 72,414 | $395,960 | -103,650 | -58.87% | $5.47 | 13F |
| DTIL | Precision Biosciences Inc | 0.00126% | 4,675 | $19,449 | No Change | $4.16 | 13F | |
| AKRO | Akero Therapeutics Inc | -434,689 | Exited | 13F | ||||
| ATXS | Astria Therapeutics Inc | -1,552,685 | Exited | 13F | ||||
| DCTH | Delcath Systems, Inc. | -569,526 | Exited | 13F | ||||
| ETNB | 89Bio Inc | -376,804 | Exited | 13F | ||||
| RZLT | Rezolute Inc | -2,112,432 | Exited | 13F | ||||
| TRML | Tourmaline Bio Inc. | -591,882 | Exited | 13F | ||||
| VRNA | Verona Pharma PLC | -1,393,432 | Exited | 13F |